|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.09% | +182.32% |
| 08-27 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 08-27 | Argenx Completes Acquisition of Forte Biosciences | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.03% | +0.09% | +0.60% | +303.72% | +182.32% | +599.91% | +266.75% | -89.08% | - | 1.94B | |
| Average | +0.03% | +0.12% | +0.60% | +303.72% | +182.32% | +599.91% | +266.75% | -89.08% | 1.94B | ||
| Weighted average by Cap. | +0.03% | +0.12% | +0.60% | +303.72% | +182.32% | +599.91% | +266.75% | -89.08% |
- Stock Market
- Stocks
- FBRX Stock
- Sector Forte Biosciences
Select your edition
All financial news and data tailored to specific country editions
